Ganilest subcutaneous injection 0.25mg syringe, manufactured by Organon, contains Ganirelix acetate. This medication is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation for assisted reproduction techniques (ART). It is provided as a 0.25mg 0.5mL 1 tube with YJ code 2499420G1025.
Ganilest subcutaneous injection 0.25mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
